Recombinant myxoma virus lacking all poxvirus ankyrin-repeat proteins stimulates multiple cellular anti-viral pathways and exhibits a severe decrease in virulence.

Virology

Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, 1600 SW Archer Road, PO Box 100266, Gainesville FL 32610, USA.

Published: September 2014

AI Article Synopsis

  • Research on single gene knockout viruses helps understand viral gene functions, but redundancy in host genes can complicate this.
  • In this study, the researchers genetically modified the myxoma virus to disrupt multiple ankyrin-repeat proteins, observing significant effects on host cell pathways.
  • The findings highlight the roles of the poxviral ANK-R protein superfamily, showing that a complete knockout led to stronger immune responses and less severe virus effects in infected rabbits.

Article Abstract

Although the production of single gene knockout viruses is a useful strategy to study viral gene functions, the redundancy of many host interactive genes within a complex viral genome can obscure their collective functions. In this study, a rabbit-specific poxvirus, myxoma virus (MYXV), was genetically altered to disrupt multiple members of the poxviral ankyrin-repeat (ANK-R) protein superfamily, M-T5, M148, M149 and M150. A particularly robust activation of the NF-κB pathway was observed in A549 cells following infection with the complete ANK-R knockout (vMyx-ANKsKO). Also, an increased release of IL-6 was only observed upon infection with vMyx-ANKsKO. In virus-infected rabbit studies, vMyx-ANKsKO was the most extensively attenuated and produced the smallest primary lesion of all ANK-R mutant constructs. This study provides the first insights into the shared functions of the poxviral ANK-R protein superfamily in vitro and in vivo.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157118PMC
http://dx.doi.org/10.1016/j.virol.2014.06.021DOI Listing

Publication Analysis

Top Keywords

myxoma virus
8
ank-r protein
8
protein superfamily
8
recombinant myxoma
4
virus lacking
4
lacking poxvirus
4
poxvirus ankyrin-repeat
4
ankyrin-repeat proteins
4
proteins stimulates
4
stimulates multiple
4

Similar Publications

Modified Vaccinia Virus Ankara Selectively Targets Human Cancer Cells With Low Expression of the Zinc-Finger Antiviral Protein.

J Med Virol

January 2025

National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.

Oncolytic viruses are emerging as promising cancer therapeutic agents, with several poxviruses, including vaccinia virus (VACV) and myxoma virus, showing significant potential in preclinical and clinical trials. Modified vaccinia virus Ankara (MVA), a laboratory-derived VACV strain approved by the FDA for mpox and smallpox vaccination, has been shown to be incapable of replicating in human cells unless zinc finger antiviral protein (ZAP) is repressed. Notably, ZAP deficiency is prevalent in various cancer types.

View Article and Find Full Text PDF

Testing Oncolytic Myxoma Virus in Immunocompetent Mouse Model for Cancer Therapy.

Methods Mol Biol

December 2024

Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ, USA.

Oncolytic viruses (OVs) have emerged as a class of novel cancer immunotherapeutic. Members of both DNA and RNA viruses developed as OVs for treating diverse types of human cancers. Preclinical research assessing immunotherapeutic efficacy is an essential step toward further development of these OVs.

View Article and Find Full Text PDF

Evaluation of dried blood spots for serological surveys of myxoma and rabbit hemorrhagic disease viruses in their wild reservoir.

Prev Vet Med

January 2025

CIBIO, Centro de Investigação em Biodiversidade e Recursos Genéticos, InBIO Laboratório Associado, Universidade do Porto, Campus de Vairão, Vairão 4485-661, Portugal; BIOPOLIS Program in Genomics, Biodiversity and Land Planning, CIBIO, Campus de Vairão, Vairão 4485-661, Portugal; Estação Biológica de Mértola (EBM), CIBIO, Praça Luís de Camões, Mértola 7750-329, Portugal. Electronic address:

Article Synopsis
  • Myxoma (MYXV) and rabbit hemorrhagic disease (RHDV) viruses are significant threats to European rabbits, which are now considered 'Endangered' in their native habitat.
  • The study focused on evaluating the effectiveness of dried blood spots (DBS) for serological surveys of these viruses in European rabbits by comparing DBS to traditional serum samples.
  • Results showed a high level of agreement between the two methods, with DBS demonstrating strong diagnostic sensitivity and perfect specificity for both MYXV and RHDV, confirming its viability for monitoring these diseases in the wild rabbit population.
View Article and Find Full Text PDF

Treatment of glioblastoma is ineffective. Myx-M011L-KO/EGFP, a myxoma virus actively inducing apoptosis in BTICs linked to recurrence, offers innovative treatment. We loaded this construct into adipose-derived stem cells (ADSCs) to mitigate antiviral host responses and enable systemic delivery.

View Article and Find Full Text PDF

Cytokine therapy represents an attractive option to improve the outcomes of cancer patients. However, the systemic delivery of these agents often leads to severe immune-related toxicities, which can prevent their efficient clinical use. One approach to address this issue is the use of recombinant oncolytic viruses to deliver various cytokines directly to the tumor.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!